Hainan Pactil Advanced Therapeutics

Hainan Pactil Advanced Therapeutics is a biotechnology company focused on developing personalized adoptive cell therapies for the treatment of solid tumors. Established as a strategic entity in China, often associated with the Boao Lecheng International Medical Tourism Pilot Zone, the company leverages advanced T-cell receptor (TCR) technologies to target patient-specific neoantigens. Its primary focus is the development of TCR-T cell therapies that can precisely identify and eliminate cancer cells by recognizing unique mutations within a patient's tumor. The company's operations bridge international innovation in precision oncology with the rapidly growing clinical infrastructure in the Hainan region.